Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Additionally we are shipping Cystatin C Kits (116) and Cystatin C Proteins (85) and many more products for this protein.
Showing 10 out of 405 products:
Human Polyclonal CST3 Primary Antibody for EIA, WB - ABIN115497
Nicklin, Barrett: Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. in The Biochemical journal 1984
Show all 12 references for ABIN115497
Human Monoclonal CST3 Primary Antibody for ELISA, WB - ABIN969070
Helisalmi, Väkevä, Hiltunen, Soininen: Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease. in Dementia and geriatric cognitive disorders 2009
Show all 2 references for ABIN969070
Human Monoclonal CST3 Primary Antibody for EIA, WB - ABIN1106888
Rehman, Fought, Solomon: N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. in Clinical journal of the American Society of Nephrology : CJASN 2008
Show all 2 references for ABIN1106888
Mouse (Murine) Monoclonal CST3 Primary Antibody for ELISA - ABIN2000617
Mussap, Plebani: Biochemistry and clinical role of human cystatin C. in Critical reviews in clinical laboratory sciences 2004
Mouse (Murine) Polyclonal CST3 Primary Antibody for ELISA, WB - ABIN184744
Huh, Nagle, Kozak, Abrahamson, Karlsson: Structural organization, expression and chromosomal mapping of the mouse cystatin-C-encoding gene (Cst3). in Gene 1995
Human Polyclonal CST3 Primary Antibody for WB - ABIN375142
Mi, Pawlik, Sastre, Jung, Radvinsky, Klein, Sommer, Schmidt, Nixon, Mathews, Levy: Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. in Nature genetics 2007
Cystatin C demonstrated incremental benefit in the prediction of response to cardiac resynchronization therapy.
the A25T polymorphism does not cause a significant reduction in Cystatin C secretion, but instead predisposes the protein to be cleaved at an alternative signal sequence cleavage site.
Cystatin C-based eGFR (show EGFR Antibodies) is a superior prognostic parameter to creatinine-based eGFR (show EGFR Antibodies) in post-endovascular therapy peripheral artery disease patients.
Cystatin C expression was significantly downregulated in breast cancer cells with p53 (show TP53 Antibodies) mutations, and decreased cystatin C expression was associated with poor prognosis of breast cancer.
the role of the cystatin C signal peptide in pathogenesis of AD and AMD (show AMD1 Antibodies)
Results revealed that cystatin C deposition in Hereditary Cystatin C Amyloid Angiopathy is always spatially associated with arteries, i.e. parenchymal focal deposits were never seen in areas with no arteries
Serum cystatin C reflects angiographic coronary collateralization in patients with stable coronary artery disease, and cystatin C >/= 0.97 mg/L indicates a great risk of poor coronary collaterals.
the level of Cys-C in CSF should not be considered as a biomarker of ALS. Cys-C in serum may be useful as an indicator of the severity of disease and site of symptoms onset although the specificity of serum Cys-C levels in ALS was not significant.
Postoperative serum Cys (show DNAJC5 Antibodies) C appears to be a more specific and sensitive biomarker for NGAL (show LCN2 Antibodies)-positive AKI resulting from cardiopulmonary bypass surgery in infants undergoing cardiac surgery.
Data (including data from studies in mutant mice) suggest that up-regulation of CST3, as observed in plasma of mice with type 2 diabetes, down-regulates insulin (show INS Antibodies) signaling and promotes endoplasmic reticulum stress in hepatocytes but not in myotubes.
Data (including data from studies in mutant mice) suggest that up-regulation of Cst3, as observed in plasma of mice with type 2 diabetes, down-regulates insulin (show INS Antibodies) signaling and promotes endoplasmic reticulum stress in hepatocytes but not in myotubes.
Cystatin C is a potential pathogenic signal triggering neurodegeneration in multiple system atrophy.
The neuroprotective activity of CysC against Amyotrophic lateral sclerosis-linked mutant Cu/Zn-superoxide dismutase (SOD1 (show SOD1 Antibodies))-mediated toxicity.
an important role for macrophages, DC, and ROS (show ROS1 Antibodies) in diseases associated with the protease inhibitory activity or amyloidogenic properties of cystatin C.
APP (show APP Antibodies) expression stimulates NSPC proliferation; this effect is mediated via an increase in cystatin C secretion
Cystatin C, a protein targeted to the classical secretory pathway by its signal peptide sequence, is secreted by primary neurons in at least 9 different cystatin C glycoforms associated with exosomes.
The lack of cystatin C enhances Collagen-induced arthritis and primarily affects in vivo priming of the immune system
Inflammation causes downregulation of cystatin C expression in dendritic cells and reduces serum CstC levels.
Data show that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation in skin.
Data show that cystatin C effectively rescues cystatin B (show CSTB Antibodies) loss-of-function mutation, facilitating the reversal of pathophysiological changes and suggesting a novel therapeutic intervention for patients with neurodegenerative disorders.
CST3 may be required to remodel endometrial and placental tissues for close apposition between maternal and fetal vasculatures and to facilitate transplacental transport of gases, micronutrients (amino acids, glucose), and macromolecules (proteins).
Increased production of cystatin C in osteoarthritis synovium does not alleviate synovitis or cartilage pathology.
Cystatin C in milk basic protein (MBP (show MBP Antibodies)) is suggested as one of the factors inhibiting bone resorption
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes the most abundant extracellular inhibitor of cysteine proteases, which is found in high concentrations in biological fluids and is expressed in virtually all organs of the body. A mutation in this gene has been associated with amyloid angiopathy. Expression of this protein in vascular wall smooth muscle cells is severely reduced in both atherosclerotic and aneurysmal aortic lesions, establishing its role in vascular disease.
, egg-white cystatin
, cystatin C
, cystatin 3
, hypothetical protein
, bA218C14.4 (cystatin C)
, neuroendocrine basic polypeptide
, Cystatin C (cysteine proteinase inhibitor)
, colostrum thiol proteinase inhibitor
, cystatin C (amyloid angiopathy and cerebral hemorrhage)